Anchored protein kinase A signalling in cardiac cellular electrophysiology

Journal of Cellular and Molecular Medicine

Volumn 18, Issue 11, 2014, Pages 2135-2146

  Soni, Siddarth ^a,b   Scholten, Arjen ^b,c   Vos, Marc A ^a   van Veen, Toon A B ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c NETHERLANDS PROTEOMICS CENTRE   (Netherlands)

Author keywords

AKAPs; Beta adrenergic signalling; PKA; Signal transduction

Indexed keywords

BETA ADRENERGIC RECEPTOR KINASE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; ION CHANNEL;

ACTION POTENTIAL; CARDIAC MUSCLE; ELECTROPHYSIOLOGY; ENZYMOLOGY; HEART; HUMAN; METABOLISM; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION;

A KINASE ANCHOR PROTEINS; ACTION POTENTIALS; BETA-ADRENERGIC RECEPTOR KINASES; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ELECTROPHYSIOLOGY; HEART; HUMANS; ION CHANNELS; MYOCARDIUM; SIGNAL TRANSDUCTION;

EID: 84911422091     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12365     Document Type: Article

References (93)

1. Kleber AG, Rudy Y. Basic mechanisms of cardiac impulse propagation and associated arrhythmias. Physiol Rev. 2004; 84: 431-88.
2. DiFrancesco D. Characterization of single pacemaker channels in cardiac sino-atrial node cells. Nature. 1986; 324: 470-3.
3. Xiang Y, Kobilka BK. Myocyte adrenoceptor signaling pathways. Science. 2003; 300: 1530-2.
4. Oldham WM, Hamm HE. Heterotrimeric G protein activation by G-protein-coupled receptors. Nat Rev Mol Cell Biol. 2008; 9: 60-71.
5. Marx SO, Kurokawa J, Reiken S, et al. Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science. 2002; 295: 496-9.
6. Davare MA, Avdonin V, Hall DD, et al. A beta2 adrenergic receptor signaling complex assembled with the Ca2+ channel Cav1.2. Science. 2001; 293: 98-101.
7. Dodge KL, Khouangsathiene S, Kapiloff MS, et al. mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module. EMBO J. 2001; 20: 1921-30.
8. Lygren B, Carlson CR, Santamaria K, et al. AKAP complex regulates Ca2+ re-uptake into heart sarcoplasmic reticulum. EMBO Rep. 2007; 8: 1061-7.
9. Hartzell HC, Glass DB. Phosphorylation of purified cardiac muscle C-protein by purified cAMP-dependent and endogenous Ca2+-calmodulin-dependent protein kinases. J Biol Chem. 1984; 259: 15587-96.
10. El-Armouche A, Pohlmann L, Schlossarek S, et al. Decreased phosphorylation levels of cardiac myosin-binding protein-C in human and experimental heart failure. J Mol Cell Cardiol. 2007; 43: 223-9.
11. Taylor SS, Ilouz R, Zhang P, et al. Assembly of allosteric macromolecular switches: lessons from PKA. Nat Rev Mol Cell Biol. 2012; 13: 646-58.
12. Corbin JD, Keely SL, Park CR. The distribution and dissociation of cyclic adenosine 3':5'-monophosphate-dependent protein kinases in adipose, cardiac, and other tissues. J Biol Chem. 1975; 250: 218-25.
13. Hofmann F, Beavo JA, Bechtel PJ, et al. Comparison of adenosine 3':5'-monophosphate-dependent protein kinases from rabbit skeletal and bovine heart muscle. J Biol Chem. 1975; 250: 7795-801.
14. Scott JD. Cyclic nucleotide-dependent protein kinases. Pharmacol Ther. 1991; 50: 123-45.
15. Scholten A, Poh MK, van Veen TA, et al. Analysis of the cGMP/cAMP interactome using a chemical proteomics approach in mammalian heart tissue validates sphingosine kinase type 1-interacting protein as a genuine and highly abundant AKAP. J Proteome Res. 2006; 5: 1435-47.
16. Scholten A, van Veen TA, Vos MA, et al. Diversity of cAMP-dependent protein kinase isoforms and their anchoring proteins in mouse ventricular tissue. J Proteome Res. 2007; 6: 1705-17.
17. Kritzer MD, Li J, Dodge-Kafka K, et al. AKAPs: the architectural underpinnings of local cAMP signaling. J Mol Cell Cardiol. 2012; 52: 351-8.
18. Carr DW, Stofko-Hahn RE, Fraser ID, et al. Interaction of the regulatory subunit (RII) of cAMP-dependent protein kinase with RII-anchoring proteins occurs through an amphipathic helix binding motif. J Biol Chem. 1991; 266: 14188-92.
19. Feliciello A, Cardone L, Garbi C, et al. Yotiao protein, a ligand for the NMDA receptor, binds and targets cAMP-dependent protein kinase II(1). FEBS Lett. 1999; 464: 174-8.
20. Carr DW, Stofko-Hahn RE, Fraser ID, et al. Localization of the cAMP-dependent protein kinase to the postsynaptic densities by A-kinase anchoring proteins. Characterization of AKAP 79. J Biol Chem. 1992; 267: 16816-23.
21. Newlon MG, Roy M, Morikis D, et al. The molecular basis for protein kinase A anchoring revealed by solution NMR. Nat Struct Biol. 1999; 6: 222-7.
22. Newlon MG, Roy M, Morikis D, et al. A novel mechanism of PKA anchoring revealed by solution structures of anchoring complexes. EMBO J. 2001; 20: 1651-62.
23. Huang LJ, Durick K, Weiner JA, et al. D-AKAP2, a novel protein kinase A anchoring protein with a putative RGS domain. Proc Natl Acad Sci. 1997; 94: 11184-9.
24. Huang LJ, Durick K, Weiner JA, et al. Identification of a novel protein kinase A anchoring protein that binds both type I and type II regulatory subunits. J Biol Chem. 1997; 272: 8057-64.
25. Burgers PP, Ma Y, Margarucci L, et al. A small novel A-kinase anchoring protein (AKAP) that localizes specifically protein kinase A-regulatory subunit I (PKA-RI) to the plasma membrane. J Biol Chem. 2012; 287: 43789-97.
26. Kovanich D, van der Heyden MA, Aye TT, et al. Sphingosine kinase interacting protein is an A-kinase anchoring protein specific for type I cAMP-dependent protein kinase. ChemBioChem. 2010; 11: 963-71.
27. Fink MA, Zakhary DR, Mackey JA, et al. AKAP-mediated targeting of protein kinase A regulates contractility in cardiac myocytes. Circ Res. 2001; 88: 291-7.
28. Patel HH, Hamuro LL, Chun BJ, et al. Disruption of protein kinase A localization using a trans-activator of transcription (TAT)-conjugated A-kinase-anchoring peptide reduces cardiac function. J Biol Chem. 2010; 285: 27632-40.
29. Carlson CR, Lygren B, Berge T, et al. Delineation of type I protein kinase A-selective signaling events using an RI anchoring disruptor. J Biol Chem. 2006; 281: 21535-45.
30. Torheim EA, Jarnaess E, Lygren B, et al. Design of proteolytically stable RI-anchoring disruptor peptidomimetics for in vivo studies of anchored type I protein kinase A-mediated signalling. Biochem J. 2009; 424: 69-78.
31. Gold MG, Lygren B, Dokurno P, et al. Molecular basis of AKAP specificity for PKA regulatory subunits. Mol Cell. 2006; 24: 383-95.
32. Nijholt IM, Ostroveanu A, Scheper WA, et al. Inhibition of PKA anchoring to A-kinase anchoring proteins impairs consolidation and facilitates extinction of contextual fear memories. Neurobiol Learn Mem. 2008; 90: 223-9.
33. Christian F, Szaszak M, Friedl S, et al. Small molecule AKAP-protein kinase A (PKA) interaction disruptors that activate PKA interfere with compartmentalized cAMP signaling in cardiac myocytes. J Biol Chem. 2011; 286: 9079-96.
34. Murphy BJ, Rogers J, Perdichizzi AP, et al. cAMP-dependent phosphorylation of two sites in the alpha subunit of the cardiac sodium channel. J Biol Chem. 1996; 271: 28837-43.
35. Zhou J, Shin HG, Yi J, et al. Phosphorylation and putative ER retention signals are required for protein kinase A-mediated potentiation of cardiac sodium current. Circ Res. 2002; 91: 540-6.
36. Costa MR, Casnellie JE, Catterall WA. Selective phosphorylation of the alpha subunit of the sodium channel by cAMP-dependent protein kinase. J Biol Chem. 1982; 257: 7918-21.
37. Tibbs VC, Gray PC, Catterall WA, et al. AKAP15 anchors cAMP-dependent protein kinase to brain sodium channels. J Biol Chem. 1998; 273: 25783-8.
38. Cantrell AR, Tibbs VC, Westenbroek RE, et al. Dopaminergic modulation of voltage-gated Na+ current in rat hippocampal neurons requires anchoring of cAMP-dependent protein kinase. J Neurosci. 1999; 19: RC21.
39. Hulme JT, Lin TW, Westenbroek RE, et al. Beta-adrenergic regulation requires direct anchoring of PKA to cardiac CaV1.2 channels via a leucine zipper interaction with A kinase-anchoring protein 15. Proc Natl Acad Sci. 2003; 100: 13093-8.
40. Fuller MD, Emrick MA, Sadilek M, et al. Molecular mechanism of calcium channel regulation in the fight-or-flight response. Sci Signal. 2010; 3: 70.
41. Gao T, Yatani A, Dell'Acqua ML, et al. cAMP-dependent regulation of cardiac L-type Ca2+ channels requires membrane targeting of PKA and phosphorylation of channel subunits. Neuron. 1997; 19: 185-96.
42. Nichols CB, Rossow CF, Navedo MF, et al. Sympathetic stimulation of adult cardiomyocytes requires association of AKAP5 with a subpopulation of L-type calcium channels. Circ Res. 2010; 107: 747-56.
43. Valdivia HH, Kaplan JH, Ellis-Davies GC, et al. Rapid adaptation of cardiac ryanodine receptors: modulation by Mg2+ and phosphorylation. Science. 1995; 267: 1997-2000.
44. Xiao B, Zhong G, Obayashi M, et al. Ser-2030, but not Ser-2808, is the major phosphorylation site in cardiac ryanodine receptors responding to protein kinase A activation upon beta-adrenergic stimulation in normal and failing hearts. Biochem J. 2006; 396: 7-16.
45. Wehrens XH, Lehnart SE, Reiken S, et al. Ryanodine receptor/calcium release channel PKA phosphorylation: a critical mediator of heart failure progression. Proc Natl Acad Sci. 2006; 103: 511-8.
46. Kapiloff MS, Jackson N, Airhart N. mAKAP and the ryanodine receptor are part of a multi-component signaling complex on the cardiomyocyte nuclear envelope. J Cell Sci. 2001; 114: 3167-76.
47. Kapiloff MS, Schillace RV, Westphal AM, et al. mAKAP: an A-kinase anchoring protein targeted to the nuclear membrane of differentiated myocytes. J Cell Sci. 1999; 112: 2725-36.
48. Dodge-Kafka KL, Soughayer J, Pare GC, et al. The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways. Nature. 2005; 437: 574-8.
49. Bers DM. Cardiac excitation-contraction coupling. Nature. 2002; 415: 198-205.
50. Szentesi P, Pignier C, Egger M, et al. Sarcoplasmic reticulum Ca2+ refilling controls recovery from Ca2+-induced Ca2+ release refractoriness in heart muscle. Circ Res. 2004; 95: 807-13.
51. Jones BW, Brunet S, Gilbert ML, et al. Cardiomyocytes from AKAP7 knockout mice respond normally to adrenergic stimulation. Proc Natl Acad Sci. 2012; 109: 17099-104.
52. Schulze DH, Muqhal M, Ledere WJ, et al. Sodium/calcium exchanger (NCX1) macromolecular complex. J Biol Chem. 2003; 278: 28849-55.
53. Zakhary DR, Fink MA, Ruehr ML, et al. Selectivity and regulation of A-kinase anchoring proteins in the heart. The role of autophosphorylation of the type II regulatory subunit of cAMP-dependent protein kinase. J Biol Chem. 2000; 275: 41389-95.
54. Caroni P, Carafoli E. Regulation of Ca2+-pumping ATPase of heart sarcolemma by a phosphorylation-dephosphorylation Process. J Biol Chem. 1981; 256: 9371-3.
55. Terrenoire C, Houslay MD, Baillie GS, et al. The cardiac IKs potassium channel macromolecular complex includes the phosphodiesterase PDE4D3. J Biol Chem. 2009; 284: 9140-6.
56. Chen L, Kurokawa J, Kass RS. Phosphorylation of the A-kinase-anchoring protein Yotiao contributes to protein kinase A regulation of a heart potassium channel. J Biol Chem. 2005; 280: 31347-52.
57. Shih M, Lin F, Scott JD, et al. Dynamic complexes of beta2-adrenergic receptors with protein kinases and phosphatases and the role of gravin. J Biol Chem. 1999; 274: 1588-95.
58. Tao J, Wang HY, Malbon CC. Protein kinase A regulates AKAP250 (gravin) scaffold binding to the beta2-adrenergic receptor. EMBO J. 2003; 22: 6419-29.
59. Diviani D, Abuin L, Cotecchia S, et al. Anchoring of both PKA and 14-3-3 inhibits the Rho-GEF activity of the AKAP-Lbc signaling complex. EMBO J. 2004; 23: 2811-20.
60. Jin J, Smith FD, Stark C, et al. Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Curr Biol. 2004; 14: 1436-50.
61. Carnegie GK, Soughayer J, Smith FD, et al. AKAP-Lbc mobilizes a cardiac hypertrophy signaling pathway. Mol Cell. 2008; 32: 169-79.
62. Carnegie GK, Smith FD, McConnachie G, et al. AKAP-Lbc nucleates a protein kinase D activation scaffold. Mol Cell. 2004; 15: 889-99.
63. Taglieri DM, Johnson KR, Burmeister BT, et al. The C-terminus of the long AKAP13 isoform (AKAP-Lbc) is critical for development of compensatory cardiac hypertrophy. J Mol Cell Cardiol. 2014; 66C: 27-40.
64. Appert-Collin A, Cotecchi S, Nenniger-Tosato M, et al. The A-kinase anchoring protein (AKAP)-Lbc-signaling complex mediates alpha1 adrenergic receptor-induced cardiomyocyte hypertrophy. Proc Natl Acad Sci. 2007; 104: 10140-5.
65. Vescovo E, Levick A, Childs C, et al. High-precision calibration of MRS thermometry using validated temperature standards: effects of ionic strength and protein content on the calibration. NMR Biomed. 2013; 26: 213-23.
66. Li J, Negro A, Lopez J, et al. The mAKAPbeta scaffold regulates cardiac myocyte hypertrophy via recruitment of activated calcineurin. J Mol Cell Cardiol. 2013; 48: 387-94.
67. Pare GC, Bauman AL, McHenry M, et al. The mAKAP complex participates in the induction of cardiac myocyte hypertrophy by adrenergic receptor signaling. J Cell Sci. 2005; 118: 5637-46.
68. Zhang L, Malik S, Kelley GG, et al. Phospholipase C epsilon scaffolds to muscle-specific A kinase anchoring protein (mAKAPbeta) and integrates multiple hypertrophic stimuli in cardiac myocytes. J Biol Chem. 2011; 286: 23012-21.
69. Kass DA. Message delivered: how myocytes control cAMP signaling. Circ Res. 2008; 102: 1002-4.
70. Bristow MR, Ginsburg R. Beta 2 receptors on myocardial cells in human ventricular myocardium. Am J Cardiol. 1986; 57: 3F-6F.
71. Aye TT, Soni S, van Veen TA, et al. Reorganized PKA-AKAP associations in the failing human heart. J Mol Cell Cardiol. 2012; 52: 511-8.
72. Zakhary DR, Moravec CS, Bond M. Regulation of PKA binding to AKAPs in the heart: alterations in human heart failure. Circulation. 2000; 101: 1459-64.
73. Soni S, Corradini E, van der Nagel R, et al. Anchored cAMP signaling in progression from hypertrophy to heart failure in a rat model of pressure overload. Eur Heart J. 2013; 34(Suppl. 1): P5715, 1065.
74. Zakhary DR, Moravec CS, Stewart RW, et al. Protein kinase A (PKA)-dependent troponin-I phosphorylation and PKA regulatory subunits are decreased in human dilated cardiomyopathy. Circulation. 1999; 99: 505-10.
75. Kass RS, Moss AJ. Long QT syndrome: novel insights into the mechanisms of cardiac arrhythmias. J Clin Invest. 2003; 112: 810-5.
76. Chen L, Marquardt ML, Tester DJ, et al. Mutation of an A-kinase-anchoring protein causes long-QT syndrome. Proc Natl Acad Sci. 2007; 104: 20990-5.
77. Piippo K, Swan H, Pasternack M, et al. A founder mutation of the potassium channel KCNQ1 in long QT syndrome: implications for estimation of disease prevalence and molecular diagnostics. J Am Coll Cardiol. 2001; 37: 562-8.
78. Splawski I, Timothy KW, Sharpe LM, et al. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell. 2004; 119: 19-31.
79. Cheng EP, Yuan C, Navedo MF, et al. Restoration of normal L-type Ca2+ channel function during Timothy syndrome by ablation of an anchoring protein. Circ Res. 2011; 109: 255-61.
80. Tingley WG, Pawlikowska L, Zaroff JG, et al. Gene-trapped mouse embryonic stem cell-derived cardiac myocytes and human genetics implicate AKAP10 in heart rhythm regulation. Proc Natl Acad Sci. 2007; 104: 8461-6.
81. Kammerer S, Burns-Hamuro LL, Ma Y, et al. Amino acid variant in the kinase binding domain of dual-specific A kinase-anchoring protein 2: a disease susceptibility polymorphism. Proc Natl Acad Sci. 2003; 100: 4066-71.
82. Lu T, Lee HC, Kabat JA, et al. Modulation of rat cardiac sodium channel by the stimulatory G protein alpha subunit. J Physiol. 1999; 518: 371-84.
83. Hulme JT, Westenbroek RE, Scheuer T, et al. Phosphorylation of serine 1928 in the distal C-terminal domain of cardiac CaV1.2 channels during beta1-adrenergic regulation. Proc Natl Acad Sci. 2006; 103: 16574-9.
84. Jackson WA, Colyer J. Translation of Ser16 and Thr17 phosphorylation of phospholamban into Ca 2+-pump stimulation. Biochem J. 1996; 316: 201-7.
85. Kurokawa J, Motoike HK, Rao J, et al. Regulatory actions of the A-kinase anchoring protein Yotiao on a heart potassium channel downstream of PKA phosphorylation. Proc Natl Acad of Sci. 2004; 101: 16374-8.
86. Kiehn J, Karle C, Thomas D, et al. HERG potassium channel activation is shifted by phorbol esters via protein kinase A-dependent pathways. J Biol Chem. 1998; 273: 25285-91.
87. Thomas D, Zhang W, Karle CA, et al. Deletion of protein kinase A phosphorylation sites in the HERG potassium channel inhibits activation shift by protein kinase A. J Biol Chem. 1999; 274: 27457-62.
88. Cui J, Melman Y, Palma E, et al. Cyclic AMP regulates the HERG K(+) channel by dual pathways. Curr Biol. 2000; 10: 671-4.
89. Mason HS, Latten MJ, Godoy LD, et al. Modulation of Kv1.5 currents by protein kinase A, tyrosine kinase, and protein tyrosine phosphatase requires an intact cytoskeleton. Mol Pharmacol. 2002; 61: 285-93.
90. Kwak YG, Hu N, Wei J, et al. Protein kinase A phosphorylation alters Kvbeta1.3 subunit-mediated inactivation of the Kv1.5 potassium channel. J Biol Chem. 1999; 274: 13928-32.
91. Koumi S, Backer CL, Arentzen CE, et al. beta-Adrenergic modulation of the inwardly rectifying potassium channel in isolated human ventricular myocytes. Alteration in channel response to beta-adrenergic stimulation in failing human hearts. J Clin Invest. 1995; 96: 2870-81.
92. Lin YF, Jan YN, Jan LY. Regulation of ATP-sensitive potassium channel function by protein kinase A-mediated phosphorylation in transfected HEK293 cells. EMBO J. 2000; 19: 942-55.
93. Liao Z, Lockhead D, Larson ED, et al. Phosphorylation and modulation of hyperpolarization-activated HCN4 channels by protein kinase A in the mouse sinoatrial node. J Gen Physiol. 2010; 136: 247-58.